Investment for health and wellbeing
Welcome to join our Q3 2025 results webcast on 30 October 2025 at 10 a.m. EETOriola operates in the Finnish and Swedish health and wellbeing markets
Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.
Interim Report Q3 2025
Oriola will publish its Interim Report January-September 2025 on Thursday 30 October 2025 at around 8.30 a.m. Welcome to join our results presentation as a live webcast at 10 a.m. on the same day.
Pareto Securities' Healthcare Conference
Oriola attended Pareto Securities' Healthcare Conference in Stockholm on 16 September 2025 with CEO Katarina Gabrielson as a speaker.
Oriola's science-based climate targets
Oriola’s ambitious science-based climate targets approved by the SBTi. This approval makes Oriola one of the companies globally recognised by the SBTi as having an approved science-based net-zero target under the SBTi Net-Zero Standard.
Annual Report 2024
Growth through strategy implementation. Find out more about Oriola's year 2024.
Latest stock exchange releases
